CHTP Soars After Positive Results For Northera

Shares of Chelsea Therapeutics International Ltd

spiked nearly 24% on Monday, after the company reported positive scientific data for Northera. CHTP reported favorable Phase III data for its drug candidate Northera, for a chronic type of low blood pressure. Chelsea's shares surged 24.31% to $1.23 at 10:45 am. Shares of CHTP have advanced 42.54% over the past month and have risen 87.41% so far this year. Read more